image
Healthcare - Medical - Diagnostics & Research - NASDAQ - US
$ 34.91
-2.03 %
$ 1.26 B
Market Cap
-0.59
P/E
Price Target Average
--8.34%
Revenue Forecast Estimate
25.78%
EBIT Estimate
45.82%
Net Income Estimate
36.97%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets GRAIL, Inc.
image
Wall Street analysts predict an average 1-year price target for GRAL of $32 , with forecasts ranging from a low of $32 to a high of $32 .
GRAL Lowest Price Target Wall Street Target
32 USD -8.34%
GRAL Average Price Target Wall Street Target
32 USD -8.34%
GRAL Highest Price Target Wall Street Target
32 USD -8.34%
Price
Max Price Target
Min Price Target
Average Price Target
60605555505045454040353530302525202015151010Sep '24Sep '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26Jul '26Jul '26
REVENUE FORECAST

Revenue Forecast Chart GRAL

image
$350.0m$350.0m$300.0m$300.0m$250.0m$250.0m$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.0202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart GRAL

image
$0.0$0.0($200.0m)($200.0m)($400.0m)($400.0m)($600.0m)($600.0m)($800.0m)($800.0m)($1.0b)($1.0b)($1.2b)($1.2b)($1.4b)($1.4b)202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart GRAL

image
$0.0$0.0($1.0b)($1.0b)($2.0b)($2.0b)($3.0b)($3.0b)($4.0b)($4.0b)($5.0b)($5.0b)($6.0b)($6.0b)202420242025202520262026202720272028202820292029